Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Oostra

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
MLO: Medical Laboratory Observer|May 10, 1986
A primer for proficiency testingR Oostra
MLO: Medical Laboratory Observer|June 9, 1987
Seldom-run tests: are you reliable or liable?R Oostra
MLO: Medical Laboratory Observer|April 10, 1986
On the road with a consulting technologistR Oostra, B Hofer
MLO: Medical Laboratory Observer|October 6, 1988
Six steps to deal with complaints about lab serviceR Oostra, L Young
Healthcare Executive|October 6, 1990
No violins, no apologies necessary: considering a career as a rural hospital executiveC J Kiecker, R Oostra
Breast Cancer (Dove Medical Press)|August 13, 2014
Role of trastuzumab emtansine in the treatment of HER2-positive breast cancerDrew R Oostra, Erin R Macrae
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|October 7, 2016
Romidepsin-associated cardiac toxicity and ECG changes: A case report and review of the literatureZachary T Rivers, Drew R Oostra, James S Westholder, et al.
Molecular and Cellular Endocrinology|January 11, 2015
Association of osteoprotegerin and bone loss after adjuvant chemotherapy in early-stage breast cancerDrew R Oostra, Maryam B Lustberg, Raquel E Reinbolt, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
MLO: Medical Laboratory Observer|May 10, 1986
A primer for proficiency testingR Oostra
MLO: Medical Laboratory Observer|June 9, 1987
Seldom-run tests: are you reliable or liable?R Oostra
MLO: Medical Laboratory Observer|April 10, 1986
On the road with a consulting technologistR Oostra, B Hofer
MLO: Medical Laboratory Observer|October 6, 1988
Six steps to deal with complaints about lab serviceR Oostra, L Young
Healthcare Executive|October 6, 1990
No violins, no apologies necessary: considering a career as a rural hospital executiveC J Kiecker, R Oostra
Breast Cancer (Dove Medical Press)|August 13, 2014
Role of trastuzumab emtansine in the treatment of HER2-positive breast cancerDrew R Oostra, Erin R Macrae
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|October 7, 2016
Romidepsin-associated cardiac toxicity and ECG changes: A case report and review of the literatureZachary T Rivers, Drew R Oostra, James S Westholder, et al.
Molecular and Cellular Endocrinology|January 11, 2015
Association of osteoprotegerin and bone loss after adjuvant chemotherapy in early-stage breast cancerDrew R Oostra, Maryam B Lustberg, Raquel E Reinbolt, et al.
Pageof 1